0.9 % Sodium Chloride Injection, USP, BD PosiFlush SP Syringe
K-Number: K250884 · 2025-12-02
Device Summary
Frequently Asked Questions
What is the 0.9 % Sodium Chloride Injection, USP, BD PosiFlush SP Syringe?
0.9 % Sodium Chloride Injection, USP, BD PosiFlush SP Syringe is a medical device that received FDA 510(k) clearance on 2025-12-02. It is manufactured by Becton, Dickinson and Company. The 510(k) number is K250884.
When was 0.9 % Sodium Chloride Injection, USP, BD PosiFlush SP Syringe approved by the FDA?
0.9 % Sodium Chloride Injection, USP, BD PosiFlush SP Syringe received FDA 510(k) clearance on 2025-12-02, under approval number K250884.
What company makes 0.9 % Sodium Chloride Injection, USP, BD PosiFlush SP Syringe?
0.9 % Sodium Chloride Injection, USP, BD PosiFlush SP Syringe is manufactured by Becton, Dickinson and Company.
What is the FDA product code for 0.9 % Sodium Chloride Injection, USP, BD PosiFlush SP Syringe?
The FDA product code for 0.9 % Sodium Chloride Injection, USP, BD PosiFlush SP Syringe is NGT.
Related Clinical Trials
Other Devices by Becton, Dickinson and Company
Related Devices (Code: NGT)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.